Rigel pharmaceuticals inc (RIGL)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Total revenues

59,288

44,509

4,484

20,383

-

-

-

-

-

-

-

Contract revenues from collaborations

-

-

-

-

28,895

8,250

7,150

2,250

4,750

125,000

750

Costs and expenses:
Cost of product sales

906

287

-

-

-

-

-

-

-

-

-

Research and development

52,885

46,903

46,269

63,446

62,825

67,696

75,328

78,778

69,350

64,392

90,743

Selling, general and administrative

74,588

70,002

37,831

20,908

-

-

-

-

-

-

-

General and administrative

-

-

-

-

17,813

22,501

19,612

22,849

21,768

25,291

20,903

Restructuring charges

-

-

-

5,770

-

-

1,679

-

-

-

1,141

Loss on sublease

-

-

-

-

-

9,302

-

-

-

-

-

Total costs and expenses

128,379

117,192

84,100

90,124

80,638

99,499

96,619

101,627

91,118

89,683

112,787

Income (Loss) from operations

-69,091

-72,683

-79,616

-69,741

-51,743

-91,249

-89,469

-99,377

-86,368

35,317

-112,037

Interest income

2,532

2,203

892

437

222

243

426

520

420

303

600

Interest expense

335

-

-

-

-

-

-

-

25

91

203

Gain on disposal of assets

-

-

732

88

57

98

16

17

-

-

-

Other income

-

-

-

-

-

-

-

-

-

2,361

0

Income (loss) before income taxes

-

-

-

-

-

-

-

-

-

-

-111,640

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-93

Net income (loss)

-66,894

-70,480

-77,992

-69,216

-51,464

-90,908

-89,027

-98,840

-85,973

37,890

-111,547

Net income (loss) per share, basic and diluted
Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

0.73

-2.73

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

0.72

-2.73

Weighted average shares used in computing net income (loss) per share
Basic (in shares)

-

-

-

-

-

-

-

-

-

52,055

40,876

Diluted (in shares)

-

-

-

-

-

-

-

-

-

52,573

40,876

Net loss per share, basic and diluted (in dollars per share)

-0.40

-0.44

-0.62

-0.73

-0.58

-1.04

-1.02

-1.32

-1.36

-

-

Weighted average shares used in computing net income (loss) per share, basic and diluted (in shares)

167,400

160,529

126,324

94,387

88,434

87,662

87,288

74,967

63,329

-

-

Product sales, net
Total revenues

43,772

13,947

-

-

-

-

-

-

-

-

-

Contract revenues from collaborations
Total revenues

15,516

30,562

4,484

20,383

-

-

-

-

-

-

-